We are live on ! Find out more
REVBU

Revelation Biosciences, Inc. Unit
REVBU

Delisted

REVBU was delisted on the 11th of January, 2023.

Back to rankings

1 hedge funds and large institutions have $22K invested in Revelation Biosciences, Inc. Unit in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CFN
Cordasco Financial Network
Florida
+$22.4K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CFN
1
Cordasco Financial Network
Florida
$22K +$22.4K +5,000 New

REVBU Hedge Fund Activity: Q2 2022 in Review

1 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences, Inc. Unit (REVBU) for Q2 2022, worth a combined $22K.

Buyers outnumbered sellers: 1 fund opened new REVBU positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Cordasco Financial Network, opening a new position worth an estimated $22.4K.

  • 1 institutional investor held Revelation Biosciences, Inc. Unit (REVBU) as of Q2 2022, up from 0 in Q1 2022.
  • Funds reported $22K of Revelation Biosciences, Inc. Unit stock for Q2 2022.
  • 1 fund opened new Revelation Biosciences, Inc. Unit positions in Q2 2022 and 0 closed out, a net change of +1 holder.
  • The largest Revelation Biosciences, Inc. Unit buyer in Q2 2022 was Cordasco Financial Network, an estimated $22.4K added.

Based on aggregated 13F filings for Q2 2022.